Depletion of Ikaros, Aiolos, and CK1α is particularly toxic for malignant cells in hematological cancers, accounting for FDA approval of thalidomide-like drugs for multiple myeloma [61,126]. Here, IKZF1 is linked to AL amyloidosis.